We are pioneering a new era of medicines Transforming the lives of patients living with serious diseases

At CRISPR Therapeutics, our aim is to find cures for people suffering from serious diseases through transformative gene-based medicines.

The first-ever CRISPR-based therapy is a direct reflection of our patient-forward philosophy. This CRISPR/Cas9 therapy is now approved in some countries for certain eligible people living with sickle cell disease or transfusion-dependent beta thalassemia. And we have only begun to see the applications for CRISPR technology. We believe this once-in-a-generation breakthrough will make an impact for generations to come.

From our bench scientists to our development team to our executive leaders, we see each team member as a pioneer of what’s next for our organization and the field of medicine as a whole.